Al-Chalabi, Ammar;
Andersen, Peter M.;
Berg, Leonard H. van den;
Carvalho, Mamede De;
Chiò, Adriano;
Couratier, Philippe;
Damme, Philip Van;
Hardiman, Orla;
Kozakiewicz, Magdalena Kuźma-;
Ludolph, Albert;
McDermott, Christopher J.;
Mora, Jesus S.;
Petri, Susanne;
Probyn, Katrin;
Reviers, Evy;
Salachas, François;
Silani, Vincenzo;
Tysnes, Ole-Bjørn;
Villanueva, Gemma;
Weber, Markus.
This update of the guideline on the management of amyotrophic lateral sclerosis (ALS) was commissioned by the European Academy of Neurology (EAN) and prepared in collaboration with the European Reference Network for Neuromuscular Diseases (ERN EURO-NMD) and the support of the European Network for the Cur...
Sclérose latérale amyotrophique/traitement médicamenteux,
Équipe soignante/normes,
Spasticité musculaire/thérapie,
Ptyalisme/traitement médicamenteux,
Riluzole/usage thérapeutique,
Neuroprotecteurs/usage thérapeutique,
Baclofène/usage thérapeutique,
Antagonistes muscariniques/usage thérapeutique,
Récepteurs GABA-A/usage thérapeutique,
Anxiété/traitement médicamenteux,
Gestion de la douleur
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for people with multiple sclerosis by promoting prompt and effective symptom management and relapse treatment, and comprehensive reviews.
NICE has also produced technology ...
Sclérose en plaques/thérapie,
Sclérose en plaques/diagnostic,
Ataxie/thérapie,
Inbiteurs sélectifs de la recapture de la sérotonine/usage thérapeutique,
Fatigue/thérapie,
Sclérose en plaques/rééducation et réadaptation,
Fatigue/traitement médicamenteux,
Mobilité réduite,
Spasticité musculaire/traitement médicamenteux,
Dystonie/traitement médicamenteux,
Tremblement/traitement médicamenteux
This guideline covers prescribing of cannabis-based medicinal products for people with intractable
nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy....
Solari, A;
Giordano, A;
Sastre-Garriga, J;
Köpke, S;
Rahn, A. C;
Kleiter, I;
Aleksovska, K;
Battaglia, M. A;
Bay, J;
Copetti, M;
Drulovic, J;
Kooij, L;
Mens, J;
Meza Murillo, E. R;
Milanov, I;
Milo, R;
Pekmezovic, T;
Vosburgh, J;
Silber, E;
Veronese, S;
Patti, F;
Voltz, R;
Oliver, D.
Background and purpose
Patients with severe, progressive multiple sclerosis (MS) have complex physical and psychosocial needs, typically over several years. Few treatment options are available to prevent or delay further clinical worsening in this population. The objective was to develop an evidence-base...
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy....
This guideline covers care and support for adults with cerebral palsy. It aims to improve health and
wellbeing, promote access to services and support participation and independent living....
This guideline covers managing spasticity and co-existing motor disorders and their early musculoskeletal complications in children and young people (from birth up to their 19th birthday) with non-progressive brain disorders. It aims to reduce variation in practice and help healthcare professionals to se...
